1.
Emerg Infect Dis
; 29(11): 2358-2361, 2023 11.
Article
in English
| MEDLINE
| ID: mdl-37877627
ABSTRACT
The Israeli Prison Services implemented a hepatitis C virus (HCV) elimination program in 2020. Inmates considered high risk for HCV were offered serology; HCV-seropositive participants were offered HCV RNA testing. Among participants, 7.0% had detectable HCV RNA and were offered antiviral drug therapy. This program reduced HCV burden among incarcerated persons.